Angelo Ravelli, MD, is Scientific Director of the Giannina Gaslini Institute of Genoa, Italy and Professor of Pediatrics at the University of Genoa, Italy. His field of clinical and research activity focuses on pediatric rheumatology. He has been President of the Pediatric Rheumatology European Society (PRES) and of the Italian Society of Pediatric Rheumatology (ReumaPed), Chair of the Pediatric Standing Committee of the European Alliance of Associations for Rheumatology (EULAR), and is currently President of the network of Italian pediatric research hospitals (Rete IDEA), Editor-in-Chief of Pediatric Rheumatology, and Convenor of the EULAR Online Course in Pediatric Rheumatology. He is honorary member of PReS, ReumaPed and EULAR and has been assigned the 2025 Master Award by the American College of Rheumatology (ACR).

Professor Ravelli has received numerous grants and awards, including the Gerolamo Gaslini Prize for Excellence in Research in 2004, a grant from the Myositis Foundation to conduct a multinational study on the long-term outcome of juvenile dermatomyositis, a grant from the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) to conduct the project aimed to develop the new classification criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis, and a grant from the Italian Drug Agency (AIFA) to perform a randomized trial on the comparison of the efficacy and safety of intraarticular corticosteroid injections with or without methotrexate in children with oligoarticular juvenile idiopathic arthritis.

Professor Ravelli has been the chairman of the International Consensus Conference which led to the development of the 2016 classification criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis, of the International Task Force that developed the recommendations for the treat-to-target strategy in juvenile idiopathic arthritis (2018), and of the International Task Force that developed the recommendations for the treat-to-target strategy in juvenile dermatomyositis (2024).

Professor Ravelli is author or co-author of more than 500 peer-reviewed articles and has been invited as speaker in more than 300 international congresses in more than 50 countries. On Scopus, he has more than 29,000 citations and an H index of 89.